Circulating chemokines in patients with autoimmune thyroid diseases

Area of Science:

• Immunology
• Endocrinology
• Molecular Biology

Background:

• Chemokines are crucial for immune cell recruitment in inflammatory responses.
• Autoimmune endocrine diseases like Graves' disease (GD) and Hashimoto's thyroiditis (HT) involve complex immunological mechanisms.
• Previous research on chemokine serum levels in thyroid disease shows conflicting results.

Purpose of the Study:

• To investigate and compare serum concentrations of specific chemokines (CCL2, CCL5, CXCL9, CXCL10) in patients with GD, HT, and nontoxic nodular thyroid disease (NNT).
• To explore the potential relationship between chemokine levels and disease activity or clinical parameters in GD.

Main Methods:

• Serum samples were collected from patients diagnosed with GD, HT, and NNT.
• Circulating concentrations of CCL2, CCL5, CXCL9, and CXCL10 were quantified using appropriate assays.
• Statistical analyses were performed to compare chemokine levels between disease groups and correlate them with clinical data.

Main Results:

• CCL5 levels were significantly elevated in GD patients compared to HT and NNT groups.
• CXCL10 levels were significantly lower in GD patients compared to HT patients.
• CXCL9 levels showed significant differences between GD patients in relapse versus remission.

Conclusions:

• Serum chemokine profiles, specifically CCL5 and CXCL10, differ between GD and HT, indicating distinct immunopathogenic pathways.
• CXCL9 levels may serve as a potential biomarker for disease activity in GD.
• These findings highlight the varied roles of chemokines in different thyroid autoimmune conditions.